GLP-1 Medication-Related Hair Loss

Understanding Hair Loss Associated with GLP-1 Medications
Hair thinning or increased shedding may occur in some individuals during or following treatment with GLP-1 medications. While not widely reported in initial clinical trials, this presentation is now more commonly recognised in clinical settings. In many cases, this form of hair loss is linked to physiological changes within the body, particularly rapid weight loss, rather than a direct effect of the medication on the hair follicle.
For individuals experiencing medication-related hair thinning in Sydney’s Eastern Suburbs, assessment and medically guided treatment options are available.

What is GLP-1 Medication-Related Hair Loss?
GLP-1 medication-related hair loss typically presents as diffuse thinning across the scalp. This means there is a general reduction in hair density rather than loss in specific patterned areas.
This type of hair shedding is often associated with a condition known as telogen effluvium, which can be triggered by physiological stressors such as significant weight loss or metabolic changes.

What Causes Hair Loss While Using GLP-1 Medications?
Several contributing factors may be involved in hair thinning associated with GLP-1 medications.
Telogen effluvium is considered the most common mechanism. This occurs when a larger proportion of hair follicles shift from the active growth phase into the resting phase, resulting in increased shedding several months later.
Nutritional factors may also play a role. Rapid weight loss can sometimes be associated with reduced intake or absorption of nutrients important for hair growth, including protein, iron, zinc, and essential fatty acids.
Metabolic and hormonal changes associated with weight loss may influence the hair cycle, although these are generally secondary contributors.
It is also important to consider other potential causes of hair loss, such as thyroid dysfunction or androgenetic alopecia, which may coexist.

Physiological Changes in GLP-1 Related Hair Loss
Hair cycle disruption is a key feature, with an increased proportion of follicles entering the resting phase.
Follicular stress may occur due to systemic physiological changes.
Temporary changes in the scalp environment, including microcirculation and inflammatory pathways, may also contribute.

Signs and Symptoms
Diffuse thinning across the scalp may become noticeable over time.
Increased hair shedding may be observed when brushing, washing, or styling.
Reduction in ponytail thickness may be reported.
The natural hair part may appear wider due to reduced density.
These changes often occur two to four months after the triggering event, such as rapid weight loss.

Treatment Options for GLP-1 Related Hair Loss
Management focuses on supporting the hair cycle, maintaining scalp health, and addressing contributing factors where possible.
At Beauty by Doctor in Bondi Junction, treatment approaches are tailored following clinical assessment and may include a combination of modalities.

Calecim® Professional Scalp Therapy
Calecim® Professional contains bioactive proteins, growth factors, and cytokines derived from umbilical cord lining cells. This approach aims to support follicle function and the natural hair growth cycle.

Microneedling for the Scalp
Microneedling creates controlled micro-channels in the scalp, supporting circulation and enhancing the delivery of topical treatments. This process may assist in optimising the scalp environment.

LED Light Therapy
LED therapy utilises specific wavelengths of light to support cellular activity and scalp health. It may assist in reducing inflammation and supporting follicular function.

Prescription Medications
Following consultation, personalised topical formulations may be prescribed where appropriate. These may target scalp circulation, inflammation, and follicular activity.
Treatment selection is based on individual assessment, including medical history, contributing factors, and pattern of hair loss.

Ongoing Management
In cases of telogen effluvium related to weight loss, hair density may recover over time. Treatment may support this process.
For individuals continuing GLP-1 medications or with underlying predispositions, a maintenance approach may be considered to support ongoing scalp and follicle health.

Frequently Asked Questions

How soon may changes be observed following treatment?
Changes in shedding patterns may be noticed within several weeks. Visible regrowth may take several months, reflecting the natural hair cycle.

Is scalp microneedling uncomfortable?
Discomfort varies between individuals. Measures may be used to support patient comfort where appropriate.

Who may be suitable for treatment?
Individuals experiencing diffuse hair thinning or increased shedding during or after GLP-1 medication use may be considered. Suitability is determined during consultation.

Are results permanent?
If hair loss is related to a temporary trigger, recovery may occur over time. Where contributing factors persist, ongoing management may be required.

Consultation and Assessment
A personalised consultation allows for assessment of contributing factors and discussion of appropriate treatment options.

Suitability for treatment is determined during consultation. All medical and cosmetic procedures carry risks, and outcomes vary between individuals. While complications are uncommon, it is important that potential risks, including rare adverse events, are understood. For more information, please refer to our Treatment Complications page: https://beautybydoctor.com/pages/concerns/treatment-complications